北美颅颌面植入物市场 – 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

北美颅颌面植入物市场 – 行业趋势及 2029 年预测

  • Medical Devices
  • Published Report
  • Jan 2022
  • North America
  • 350 页面
  • 桌子數: 155
  • 图号: 47

>北美颅颌面植入物市场,按类型(骨移植替代品、中面部植入物、颅骨/神经植入物、下颌正颌植入物、牵引系统、颅皮瓣固定系统、患者特定植入物 (PSI)、全颞下颌 (TMJ) 置换系统、硬膜修复产品等)、结构材料(金属、骨移植替代品、聚合物/生物材料等)、应用部位(内固定器、外固定器)、手术类型(重建手术、创伤手术、整形手术、正颌手术、牙科手术、耳鼻喉手术等)、属性类型(不可吸收固定器、可吸收固定器)、最终用户(医院、专科诊所、创伤中心、门诊手术中心(ASCS)、其他)、分销渠道(直接招标、零售),国家(美国、加拿大、墨西哥)行业趋势与预测至 2029 年。

北美颅颌面植入物市场

市场分析与洞察:北美颅颌面植入物市场

预计北美颅颌面植入物市场将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析,在 2022 年至 2029 年的预测期内,该市场的复合年增长率为 8.0%,预计到 2029 年将达到 29.0522 亿美元。技术进步的不断增加是预测期内推动市场需求的主要驱动力。  

颅颌面植入物用于颅颌面手术。由于母亲缺乏叶酸或基因突变,在分娩过程中会出现颅颌面异常。面部缺陷还会损害说话、进食、语言,并导致牙齿问题和听力丧失。它通常用于治疗头部、颈部、面部、颌骨、口腔颌面部硬组织和软组织的损伤、缺陷和疾病。

老年人口的增加以及肠癌和膀胱癌患病率的上升正在加速市场的增长。行业先进技术的采用刺激了市场的增长,因此,患者对手术专用植入物的需求不断增长可能会在预测期内推动市场增长。

颅颌面植入物市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息,分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和市场情况,请联系我们获取分析师简报,我们的团队将帮助您创建收入影响解决方案,以实现您的预​​期目标。

北美颅颌面植入物市场

北美颅颌面植入物市场范围和市场规模

颅颌面植入物市场根据类型、建筑材料、应用部位、手术类型、属性类型、最终用户和分销渠道进行细分。

  • 根据类型,颅颌面植入物市场细分为骨移植替代品、中面部植入物、颅骨/神经植入物、下颌正颌植入物、牵引系统、颅骨瓣固定系统、患者专用植入物 (PSI)、全颞下颌 (TMJ) 置换系统、硬膜修复产品等。由于全球老年人口增加,预计 2022 年骨移植替代品将在全球颅颌面植入物市场占据主导地位。
  • 根据结构材料,颅颌面植入物市场分为金属、骨移植替代品、聚合物/生物材料和其他材料。随着技术进步和政府医疗支出的增加,预计到 2022 年,金属将在全球颅颌面植入物市场占据主导地位。
  • 根据应用部位,颅颌面植入物市场分为外固定器和内固定器。随着产品发布和收购的增加,预计到 2022 年,外固定器将在全球颅颌面植入物市场占据主导地位。
  • 根据手术类型,颅颌面植入物市场细分为重建手术、创伤手术、整形手术、正颌手术、牙科手术、耳鼻喉手术等。随着手术和程序数量的增加,预计到 2022 年,重建手术将在全球颅颌面植入物市场中占据主导地位。
  • 根据属性类型,颅颌面植入物市场分为可吸收固定器和不可吸收固定器。2022 年,可吸收固定器预计将主导全球颅颌面植入物市场,因为它们可以提供更好的效果,同时减少并发症。
  • 根据最终用户,颅颌面植入物市场分为医院、专科诊所、创伤中心、门诊手术中心 (ASCS) 和其他。到 2022 年,随着患者和手术数量的增加,医院预计将主导全球颅颌面植入物市场。
  • 根据分销渠道,颅颌面植入物市场分为直接招标和零售。 2022 年,直接招标预计将主导全球颅颌面植入物市场,因为它们拥有来自主要市场参与者的所有主要产品。

颅颌面植入物市场国家/地区分析

颅颌面植入物市场根据类型、建筑材料、应用部位、手术类型、属性类型、最终用户和分销渠道进行细分。

颅颌面植入物市场报告涵盖的国家包括美国、加拿大和墨西哥。

  • 在北美,由于主要市场参与者的存在,预计美国将占据市场主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。

私营部门资金的增加和技术的进步正在推动颅颌面植入物市场的增长 

颅颌面植入物市场还为您提供每个国家植入物行业增长的详细市场分析,包括进步、技术和监管环境变化的影响。数据涵盖 2011 年至 2019 年的历史时期。

竞争格局和颅颌面植入物市场份额分析

颅颌面植入物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对颅颌面植入物市场的关注有关。

涉足颅颌面植入物市场的主要公司有 Zimmer Biomet、Stryker、Johnson and Johnson Services Inc.、Medtronic、KLS Martin Group、Delphos Implants、Osteomed、Anatomics Pty Ltd、Bioplate Inc.、Calavera Surgical Design、Innovasis、Integra LifeSciences Holdings Corp.、Dimeda Instrumente GmbH、General Implants GmbH、Jeil Medical Corporation、Xilloc Medical BV、Ortho Select GmbH、B. Braun Melsungen AG、MONDEAL Medical Systems GmbH、OssDsign AB、TREU-Instrumente GmbH、Rebstock Instruments GmbH、3D Systems, Inc.、Medartis AG、BIOPORE SURGICALS、AlloSource、Teknimed、Poriferous、7s Medical AG、Innovation Medical GmbH、Advin Health care 和 Gesco Healthcare Pvt。 Ltd、Auxein Medical Private Limited Renishaw Plc、Ortho Max Manufacturing Company Pvt. Ltd. Vast Ortho、Skulle Implants Corporation.、PANTHERA DENTAL、Lucid Implants 等等。

  • 2021 年 10 月,AlloSource 宣布推出 AlloMend® 超大 (XL) 无细胞真皮基质 (ADM),这是 AlloMend 产品线的最新成员。这增加了公司的产品线。
  • 2021 年 8 月,美敦力公司宣布与全球耳鼻喉 (ENT) 医疗技术领导者 Intersect ENT 达成协议。美敦力收购 Intersect ENT 扩大了该公司在耳鼻喉手术中使用的产品组合。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTERS FIVE FORCES MODEL

5 INDUSTRIAL INSIGHTS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 RISING PREVALENCE RATE OF CONGENITAL FACIAL DEFORMITIES

6.1.2 INCREASE IN TRAUMA CASES AND ROAD ACCIDENTS

6.1.3 INCREASING DEMAND FOR FACIAL RECONSTRUCTION SURGERY

6.1.4 RECENT TECHNOLOGICAL ADVANCEMENTS IN CMF IMPLANTS

6.2 RESTRAINS

6.2.1 HIGH COST OF SURGERIES AND IMPLANTS

6.2.2 IMPLANT MALFUNCTION AND ASSOCIATED RISK

6.2.3 LACK OF AWARENESS IN DEVELOPING COUNTRIES

6.3 OPPORTUNITIES

6.3.1 GROWING GERIATRIC POPULATION

6.3.2 RISE IN HEALTHCARE EXPENDITURE & INFRASTRUCTURE

6.3.3 GROWING R&D ACTIVITIES AND TECHNOLOGICAL ADVANCEMENT

6.3.4 INCREASE IN DEMAND FOR CUSTOMIZED AND PATIENT-SPECIFIC IMPLANTS

6.4 CHALLENGE

6.4.1 INCREASE IN PRODUCT RECALL

6.4.2 POST SURGERY COMPLIACTION

7 COVID-19 IMPACT ON NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET

7.1 PRICE IMPACT

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY

7.4 STRATEGIC DECISIONS BY MANUFACTURERS

7.5 CONCLUSION

8 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE

8.1 OVERVIEW

8.2 BONE GRAFT SUBSTITUTE

8.2.1 NATURAL

8.2.2 SYNTHETIC

8.3 MID-FACE IMPLANTS

8.3.1 PLATES

8.3.2 SCREWS

8.4 CRANIAL/NEURO IMPLANTS

8.4.1 PLATES

8.4.2 SCREWS

8.4.3 CONTOURABLE MESHES

8.5 MANDIBULAR ORTHOGNATHIC IMPLANTS

8.5.1 PLATES

8.5.2 SCREWS

8.6 DISTRACTION SYSTEM

8.7 CRANIAL FLAP FIXATION SYSTEMS

8.8 PATIENT SPECIFIC IMPLANTS (PSI)

8.8.1 METAL

8.8.2 PLASTIC

8.8.3 OTHERS

8.8.3.1 NORMAL

8.8.3.2 3D-PRINTED

8.8.3.2.1 CAD

8.8.3.2.2 ADEPT SOFTWARE

8.8.3.2.3 CAM

8.8.3.2.4 OTHERS

8.9 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM

8.1 DURAL REPAIR PRODUCTS

8.10.1 DURAL SEALANTS

8.10.2 DURAL SUBSTITUTES

8.11 OTHERS

9 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION

9.1 OVERVIEW

9.2 METALS

9.2.1 TITANIUM AND ALLOYS

9.2.2 STAINLESS STEEL

9.2.3 POLYETHERETHERKETONE (PEEK)

9.2.4 SILICON NITRIDE

9.2.5 OTHERS

9.3 BONE GRAFT SUBSTITUTE

9.4 POLYMERS/BIOMATERIAL

9.5 OTHERS

10 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE

10.1 OVERVIEW

10.2 INTERNAL FIXATOR

10.2.1 BONE GRAFT SUBSTITUTE

10.2.2 MID-FACE IMPLANTS

10.2.3 CRANIAL/NEURO IMPLANTS

10.2.4 MANDIBULAR ORTHOGNATHIC

10.2.5 DISTRACTION SYSTEM

10.2.6 CRANIAL FLAP FIXATION SYSTEMS

10.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS

10.2.8 OTHERS

10.3 EXTERNAL FIXATOR

10.3.1 DISTRACTION SYSTEM

10.3.2 OTHERS

11 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE

11.1 OVERVIEW

11.2 RECONSTRUCTIVE SURGERY

11.2.1 BONE GRAFT SUBSTITUTE

11.2.2 MID-FACE IMPLANTS

11.2.3 CRANIAL/NEURO IMPLANTS

11.2.4 MANDIBULAR ORTHOGNATHIC

11.2.5 DISTRACTION SYSTEM

11.2.6 CRANIAL FLAP FIXATION SYSTEMS

11.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS

11.2.8 DURAL REPAIR

11.2.9 OTHERS

11.3 TRAUMA SURGERY

11.3.1 BONE GRAFT SUBSTITUTE

11.3.2 MID-FACE IMPLANTS

11.3.3 CRANIAL/NEURO IMPLANTS

11.3.4 MANDIBULAR ORTHOGNATHIC

11.3.5 DISTRACTION SYSTEM

11.3.6 CRANIAL FLAP FIXATION SYSTEMS

11.3.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS

11.3.8 DURAL REPAIR

11.3.9 OTHERS

11.4 PLASTIC SURGERIES

11.4.1 MID-FACE IMPLANTS

11.4.2 MANDIBULAR ORTHOGNATHIC

11.4.3 CRANIAL/NEURO IMPLANTS

11.4.4 DISTRACTION SYSTEM

11.4.5 CRANIAL FLAP FIXATION SYSTEMS

11.4.6 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS

11.4.7 OTHERS

11.5 ORTHOGNATHIC SURGERIES

11.5.1 BONE GRAFT SUBSTITUTE

11.5.2 MANDIBULAR ORTHOGNATHIC

11.5.3 DISTRACTION SYSTEM

11.5.4 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS

11.5.5 OTHERS

11.6 DENTAL SURGERIES

11.6.1 DISTRACTION SYSTEM

11.6.2 OTHERS

11.7 ENT SURGERIES

11.7.1 BONE GRAFT SUBSTITUTE

11.7.2 MID-FACE IMPLANTS

11.7.3 OTHERS

11.8 OTHERS

12 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE

12.1 OVERVIEW

12.2 NON-RESORBABLE FIXATORS

12.3 RESORBABLE FIXATORS

13 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER

13.1 OVERVIEW

13.2 HOSPITAL

13.3 SPECIALTY CLINICS

13.4 TRAUMA CENTERS

13.5 AMBULATORY SURGICAL CENTERS (ASCS)

13.6 OTHERS

14 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL

14.1 OVERVIEW

14.2 DIRECT TENDER

14.3 RETAIL SALES

15 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION

15.1 NORTH AMERICA

15.1.1 U.S.

15.1.2 CANADA

15.1.3 MEXICO

16 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 ZIMMER BIOMET.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 RODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENT

18.2 MEDTRONIC

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENT

18.3 DEPUY SYNTHES.

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENT

18.4 STRYKER

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 ALLOSOURCE

18.5.1 COMPANY SNAPSHOT

18.5.2 COMPANY SHARE ANALYSIS

18.5.3 PRODUCT PORTFOLIO

18.5.4 RECENT DEVELOPMENT

18.5.4.1 FDA APPROVAL

18.6 ADVIN HEALTH CARE

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 AESCULAP AG

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENT

18.8 ANATOMICS PTY LTD.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENTS

18.9 AUXEIN MEDICAL PRIVATE LIMITED

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.1 BIOPLATE INC.

18.10.1 COMPANY SNAPSHOT

18.10.2 PRODUCT PORTFOLIO

18.10.3 RECENT DEVELOPMENT

18.11 BIOPORE SURGICALS

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENT

18.12 CALAVERA SURGICAL DESIGN

18.12.1 COMPANY SNAPSHOT

18.12.2 PRODUCT PORTFOLIO

18.12.3 RECENT DEVELOPMENT

18.13 DELPHOS IMPLANTS.

18.13.1 COMPANY SNAPSHOT

18.13.2 PRODUCT PORTFOLIO

18.13.3 RECENT DEVELOPMENT

18.14 DIMEDA INSTRUMENTE GMBH

18.14.1 COMPANY SNAPSHOT

18.14.2 PRODUCT PORTFOLIO

18.14.3 RECENT DEVELOPMENTS

18.15 GENERAL-IMPLANTS GMBH

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 GESCO HEALTHCARE PVT. LTD.

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENT

18.17 INNOVATION MEDICAL GMBH

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENT

18.17.3.1 MANUFACTURING CERTIFICATION

18.18 INNOVASIS INC.

18.18.1 COMPANY SNAPSHOT

18.18.2 PRODUCT PORTFOLIO

18.18.3 RECENT DEVELOPMENT

18.19 JEIL MEDICAL CORPORATION

18.19.1 COMPANY SNAPSHOT

18.19.2 PRODUCT PORTFOLIO

18.19.3 RECENT DEVELOPMENT

18.2 KLS-MARTIN L.P.

18.20.1 COMPANY SNAPSHOT

18.20.2 PRODUCT PORTFOLIO

18.20.3 RECENT DEVELOPMENT

18.21 LUCID IMPLANTS

18.21.1 COMPANY SNAPSHOT

18.21.2 PRODUCT PORTFOLIO

18.21.3 RECENT DEVELOPMENT

18.22 MEDARTIS AG

18.22.1 COMPANY SNAPSHOT

18.22.2 PRODUCT PORTFOLIO

18.22.3 RECENT DEVELOPMENT

18.23 MONDEAL MEDICAL SYSTEMS GMBH

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 ORTHO MAX MANUFACTURING COMPANY PVT. LTD.

18.24.1 COMPANY SNAPSHOT

18.24.2 PRODUCT PORTFOLIO

18.24.3 RECENT DEVELOPMENT

18.25 ORTHO SELECT GMBH

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

18.26 OSTEOMED

18.26.1 COMPANY SNAPSHOT

18.26.2 PRODUCT PORTFOLIO

18.26.3 RECENT DEVELOPMENT

18.27 OSSDSIGN AB

18.27.1 COMPANY SNAPSHOT

18.27.2 PRODUCT PORTFOLIO

18.27.3 RECENT DEVELOPMENT

18.27.3.1 PRODUCT LAUNCH

18.27.3.2 ACQUISITION

18.28 PANTHERA DENTAL

18.28.1 COMPANY SNAPSHOT

18.28.2 PRODUCT PORTFOLIO

18.28.3 RECENT DEVELOPMENT

18.29 PORIFEROUS

18.29.1 COMPANY SNAPSHOT

18.29.2 PRODUCT PORTFOLIO

18.29.3 RECENT DEVELOPMENT

18.29.3.1 MANUFACTURING CERTIFICATION

18.3 REBSTOCK INSTRUMENTS GMBH

18.30.1 COMPANY SNAPSHOT

18.30.2 PRODUCT PORTFOLIO

18.30.3 RECENT DEVELOPMENT

18.31 RENISHAW PLC

18.31.1 COMPANY SNAPSHOT

18.31.2 REVENUE ANALYSIS

18.31.3 PRODUCT PORTFOLIO

18.31.4 RECENT DEVELOPMENT

18.32 SKULLE IMPLANTS CORPORATION.

18.32.1 COMPANY SNAPSHOT

18.32.2 PRODUCT PORTFOLIO

18.32.3 RECENT DEVELOPMENT

18.33 TEKNIMED

18.33.1 COMPANY SNAPSHOT

18.33.2 PRODUCT PORTFOLIO

18.33.3 RECENT DEVELOPMENT

18.33.3.1 MDSAP CERTIFICATION

18.34 TREU-INSTRUMENTE GMBH

18.34.1 COMPANY SNAPSHOT

18.34.2 PRODUCT PORTFOLIO

18.34.3 RECENT DEVELOPMENT

18.35 VAST ORTHO: ORTHOPEDIC IMPLANTS MANUFACTURERS

18.35.1 COMPANY SNAPSHOT

18.35.2 PRODUCT PORTFOLIO

18.35.3 RECENT DEVELOPMENTS

18.36 XILLOC MEDICAL BV

18.36.1 COMPANY SNAPSHOT

18.36.2 PRODUCT PORTFOLIO

18.36.3 RECENT DEVELOPMENT

18.37 7S MEDICAL AG

18.37.1 COMPANY SNAPSHOT

18.37.2 PRODUCT PORTFOLIO

18.37.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

表格列表

TABLE 1 UNITS/NUMBER OF PROCEDURES PERFORMED PER YEAR

TABLE 2 PRICING FOR VARIOUS PROCEDURES

TABLE 3 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 4 NORTH AMERICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 5 NORTH AMERICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 6 NORTH AMERICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 7 NORTH AMERICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 8 NORTH AMERICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 9 NORTH AMERICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 10 NORTH AMERICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 11 NORTH AMERICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 12 NORTH AMERICA DISTRACTION SYSTEM IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 13 NORTH AMERICA CRANIAL FLAP FIXATION SYSTEMS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 14 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 15 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2015-2029 (USD MILLION)

TABLE 16 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 17 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2015-2029 (USD MILLION)

TABLE 18 NORTH AMERICA TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 19 NORTH AMERICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 20 NORTH AMERICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 21 NORTH AMERICA OTHERS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 22 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 23 NORTH AMERICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 24 NORTH AMERICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 25 NORTH AMERICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 26 NORTH AMERICA POLYMERS/BIOMATERIAL IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 27 NORTH AMERICA OTHERS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 28 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 29 NORTH AMERICA INTERNAL FIXATOR IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 30 NORTH AMERICA INTERNAL FIXATOR IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 31 NORTH AMERICA EXTERNAL FIXATOR IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 32 NORTH AMERICA EXTERNAL FIXATOR IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 33 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 34 NORTH AMERICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 35 NORTH AMERICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 36 NORTH AMERICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 37 NORTH AMERICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 38 NORTH AMERICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 39 NORTH AMERICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 40 NORTH AMERICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 41 NORTH AMERICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 42 NORTH AMERICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 43 NORTH AMERICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 44 NORTH AMERICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 45 NORTH AMERICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 46 NORTH AMERICA OTHERS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 47 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2015-2029 (USD MILLION)

TABLE 48 NORTH AMERICA NON-RESORBABLE FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 49 NORTH AMERICA RESORBABLE FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 50 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 51 NORTH AMERICA HOSPITAL IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 52 NORTH AMERICA SPECIALTY CLINICS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 53 NORTH AMERICA TRAUMA CENTERS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 54 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 55 NORTH AMERICA OTHERS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 56 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)

TABLE 57 NORTH AMERICA DIRECT TENDER IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 58 NORTH AMERICA RETAIL SALES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2015-2029 (USD MILLION)

TABLE 59 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY COUNTRY, 2015-2029 (USD MILLION)

TABLE 60 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 61 NORTH AMERICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 62 NORTH AMERICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 63 NORTH AMERICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 64 NORTH AMERICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 65 NORTH AMERICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 66 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2015-2029 (USD MILLION)

TABLE 67 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 68 NORTH AMERICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2015-2029 (USD MILLION)

TABLE 69 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 70 NORTH AMERICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 71 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 72 NORTH AMERICA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 73 NORTH AMERICA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 74 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 75 NORTH AMERICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 76 NORTH AMERICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 77 NORTH AMERICA PLASTIC SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 78 NORTH AMERICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 79 NORTH AMERICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 80 NORTH AMERICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 81 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2015-2029 (USD MILLION)

TABLE 82 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 83 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)

TABLE 84 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 85 U.S. BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 86 U.S. MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 87 U.S. CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 88 U.S. MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 89 U.S. DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 90 U.S. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2015-2029 (USD MILLION)

TABLE 91 U.S. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 92 U.S. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2015-2029 (USD MILLION)

TABLE 93 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 94 U.S. METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 95 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 96 U.S. INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 97 U.S. EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 98 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 99 U.S. RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 100 U.S. TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 101 U.S. PLASTIC SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 102 U.S. ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 103 U.S. DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 104 U.S. ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 105 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2015-2029 (USD MILLION)

TABLE 106 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 107 U.S. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)

TABLE 108 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 109 CANADA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 110 CANADA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 111 CANADA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 112 CANADA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 113 CANADA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 114 CANADA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2015-2029 (USD MILLION)

TABLE 115 CANADA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 116 CANADA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2015-2029 (USD MILLION)

TABLE 117 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 118 CANADA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 119 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 120 CANADA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 121 CANADA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 122 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 123 CANADA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 124 CANADA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 125 CANADA PLASTIC SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 126 CANADA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 127 CANADA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 128 CANADA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 129 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2015-2029 (USD MILLION)

TABLE 130 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 131 CANADA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)

TABLE 132 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 133 MEXICO BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 134 MEXICO MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 135 MEXICO CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 136 MEXICO MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 137 MEXICO DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 138 MEXICO PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2015-2029 (USD MILLION)

TABLE 139 MEXICO PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2015-2029 (USD MILLION)

TABLE 140 MEXICO PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2015-2029 (USD MILLION)

TABLE 141 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 142 MEXICO METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2015-2029 (USD MILLION)

TABLE 143 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 144 MEXICO INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 145 MEXICO EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2015-2029 (USD MILLION)

TABLE 146 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 147 MEXICO RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 148 MEXICO TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 149 MEXICO PLASTIC SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 150 MEXICO ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 151 MEXICO DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 152 MEXICO ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2015-2029 (USD MILLION)

TABLE 153 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2015-2029 (USD MILLION)

TABLE 154 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2015-2029 (USD MILLION)

TABLE 155 MEXICO CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2015-2029 (USD MILLION)

图片列表

FIGURE 1 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: NORTH AMERICA VS COUNTRY MARKET ANALYSIS

FIGURE 5 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION

FIGURE 11 INCREASE IN DEMAND FOR PATIENTS SPECIFIC IMPLANTS ARE EXPECTED TO DRIVE THE NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 BONE GRAFT SUBSTITUTE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN 2022 & 2029

FIGURE 13 DRIVER, RESTRAINS, OPPORTUNITIES & CHALLENGES OF NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET

FIGURE 14 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2021

FIGURE 15 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2020-2029 (USD MILLION)

FIGURE 16 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, CAGR (2022-2029)

FIGURE 17 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 18 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2021

FIGURE 19 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2020-2029 (USD MILLION)

FIGURE 20 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, CAGR (2022-2029)

FIGURE 21 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, LIFELINE CURVE

FIGURE 22 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2021

FIGURE 23 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2020-2029 (USD MILLION)

FIGURE 24 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, CAGR (2022-2029)

FIGURE 25 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, LIFELINE CURVE

FIGURE 26 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2021

FIGURE 27 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2020-2029 (USD MILLION)

FIGURE 28 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, CAGR (2022-2029)

FIGURE 29 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 30 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2021

FIGURE 31 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2020-2029 (USD MILLION)

FIGURE 32 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, CAGR (2022-2029)

FIGURE 33 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, LIFELINE CURVE

FIGURE 34 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2021

FIGURE 35 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 36 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 37 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 38 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 39 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

FIGURE 40 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 41 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 42 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SNAPSHOT (2021)

FIGURE 43 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2021)

FIGURE 44 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 45 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 46 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE (2022-2029)

FIGURE 47 NORTH AMERICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY SHARE 2021 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The North America Craniomaxillofacial Implants Market is predicted to grow at a CAGR of 8.0% during the forecast period by 2029.
The future market value of the North America Craniomaxillofacial Implants Market is expected to reach USD 2,905.22 million by 2029.
The major players in the North America Craniomaxillofacial Implants Market are Zimmer Biomet, Stryker, Johnson and Johnson Services Inc., Medtronic, KLS Martin Group, Delphos Implants, Osteomed, Anatomics Pty Ltd, Bioplate Inc., Calavera Surgical Design, Innovasis, Integra LifeSciences Holdings Corp., Dimeda Instrumente GmbH, General Implants GmbH, Jeil Medical Corporation, Xilloc Medical BV, Ortho Select GmbH, B. Braun Melsungen AG, MONDEAL Medical Systems GmbH, etc.
The countries covered in the North America Craniomaxillofacial Implants Market are the U.S., Canada, and Mexico.